Philippines Business News API

{
    "totalArticles": 288470,
    "articles": [
        {
            "id": "a96e52df240cb4879bc2a37e3f96839e",
            "title": "Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa",
            "description": "The Investor Relations website contains information about Krystal Biotech, Inc.'s business for stockholders, potential investors, and financial analysts.",
            "content": "VYJUVEK approved for the treatment of DEB from birth with flexible administration options similar to those already granted in the United States, European Union, and Japan\nVYJUVEK is the first genetic medicine approved in the United Kingdom for the tr... [5298 chars]",
            "url": "https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-united-kingdom-mhra-approval-vyjuvekr",
            "image": "https://ir.krystalbio.com/sites/g/files/knoqqb89436/files/favicon-16x16.png",
            "publishedAt": "2026-05-18T12:06:07Z",
            "lang": "en",
            "source": {
                "id": "2a51979d24f93ec3bb68906fe48d1e71",
                "name": "Krystal Biotech, Inc",
                "url": "https://ir.krystalbio.com"
            }
        },
        {
            "id": "45d91bd754744b771cc6dc4dd4e64808",
            "title": "EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)",
            "description": "WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).",
            "content": "WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company... [2786 chars]",
            "url": "https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2346093",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/18/1061262.jpg",
            "publishedAt": "2026-05-18T11:22:40Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "62bbf6ad1da9a344fbd46e052bee91c9",
            "title": "IREN Acquires Awaken to Support Global Brand Growth",
            "description": "NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) ('IREN”) today announced the acquisition of Awaken, a creative and media agency specializing in content strategy and brand development for high-growth companies.",
            "content": "NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (\"IREN”) today announced the acquisition of Awaken, a creative and media agency specializing in content strategy and brand development for high-growth companies.\nAs part of the tr... [4289 chars]",
            "url": "https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/iren-acquires-awaken-to-support-global-brand-growth/2346081",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/18/1061247.jpg",
            "publishedAt": "2026-05-18T11:22:24Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}